Skip to main content
DMT · tryptamine psychedelic · two different molecules

DMT Harm Reduction:
Know Which One You Have.

Two substances get called "DMT". N,N-DMT is the classic smoked tryptamine and the active psychedelic in ayahuasca. 5-MeO-DMT is a separate compound that is active at much smaller amounts, feels nothing like it, and has a narrower margin for error. They are sometimes sold interchangeably. Beyond that, the biggest real-world danger with DMT is not the DMT: it is the MAOI that has to be added to make it work orally, and what that MAOI does to antidepressants and other serotonergic drugs.

This is not medical advice. DMT and 5-MeO-DMT are Schedule I in the US and controlled in most jurisdictions. If someone is unresponsive, rigid, overheating, or having trouble breathing, call emergency services. Some links on this page are affiliate links, we may earn a commission at no extra cost to you.

What is DMT?

🔬

Chemistry

N,N-dimethyltryptamine is a simple indole tryptamine found in many plants and produced in trace amounts in mammals. It is the active psychedelic in ayahuasca and the substance usually meant by "smoking DMT". Schedule I in the US.

🧠

Mechanism

Agonist at 5-HT2A and other serotonin receptors, the same family as psilocybin and LSD. Because it is a substrate for monoamine oxidase, the body clears it very fast, which is why the smoked experience is measured in minutes rather than hours.

💨

Routes

Vaporised or smoked (seconds to onset, over in minutes), injected in research settings, or taken orally with an MAOI as ayahuasca or pharmahuasca. Swallowed on its own it does close to nothing.

Supply risk

Sold as loose crystal, in "changa" herbal blends, or in sealed vape carts. Carts are the hardest to verify: you cannot see, weigh, or reagent-test a filled cartridge without emptying it, and the label is the only claim you have.

5-MeO-DMT is not N,N-DMT

Two different molecules, two different drugs. 5-MeO-DMT is active in the single-digit milligram range vaporised, where N,N-DMT is dosed in tens of milligrams. The subjective effects barely resemble each other. They are sometimes substituted for one another in the illicit market, and no home reagent can separate them because both are indoles. Full breakdown below.

Critical risks

MAOI plus serotonergic drugs

Ayahuasca means taking an MAOI. MAOIs combined with SSRIs, SNRIs, MDMA, tramadol, or other serotonergic drugs can cause serotonin syndrome, and combined with tyramine-rich foods can cause hypertensive crisis. This is the single largest source of preventable harm around DMT.

🔀

The wrong tryptamine

Taking an N,N-DMT-sized dose of 5-MeO-DMT is a serious overdose. If you cannot establish which compound you have, you do not have a dose, you have a guess.

🤕

Falling and burns

Smoked DMT takes effect faster than you can put anything down. People drop lit pipes, slump into hot glass, and fall. Sit or lie down first, and have someone sober take the pipe out of your hand.

💓

Blood pressure spike

Controlled intravenous dosing raised blood pressure, heart rate, pupil diameter, and body temperature dose-dependently. If you have uncontrolled hypertension or a known cardiac condition, that acute surge is a real reason not to.

Step 1

N,N-DMT vs 5-MeO-DMT

Both get called DMT in conversation and on packaging. Treating them as the same substance is the most consequential mistake people make with this class of drug, and it is the reason this section comes before dosing.

🌿

N,N-DMT, the classic

  • Potency: vaporised doses are commonly reported in the tens of milligrams
  • Character: intensely visual, geometric, often described as entering a distinct scene or environment
  • Duration smoked: seconds to onset, roughly 5 to 20 minutes total
  • Oral: inactive alone, active only with an MAOI (ayahuasca, pharmahuasca)
  • Where it comes from: plant sources such as Mimosa and Acacia species, or synthesised

5-MeO-DMT, the other one

Different drug
  • Potency: active in the single-digit milligram range vaporised, so a scoop sized for N,N-DMT is a large overdose
  • Character: usually described as non-visual and totally overwhelming, with loss of any sense of self or surroundings. People go rigid, thrash, vocalise, or vomit
  • Receptor profile: a nonselective serotonin agonist with its highest affinity at 5-HT1A, not the 5-HT2A-dominant profile people expect from a psychedelic
  • Metabolism: broken down mainly by MAO-A and converted by CYP2D6 into bufotenine, which is itself active. CYP2D6 varies a lot between people, so the same dose does not do the same thing to everyone
  • With an MAOI: clearance is blocked and exposure rises sharply. A forensic case report describes a death after 5-MeO-DMT was drunk in an ayahuasca-style brew containing harmine, harmaline, and tetrahydroharmine
  • Source: synthesised, or from Bufo alvarius toad secretion, where concentration is not standardised in any way
🔎

How to tell them apart

Honestly: at home, you mostly cannot. Both are indoles, so both turn Ehrlich purple. Neither has a widely available home reagent that separates it from the other. What you can do:

  • Send a sample to a lab drug-checking service that runs GC-MS or FTIR. This is the only reliable answer
  • Treat any unlabelled white or off-white tryptamine crystal as unidentified, not as N,N-DMT by default
  • Be suspicious of vape carts specifically. A sealed cart cannot be weighed or reagent-tested without emptying it, and 5-MeO-DMT has turned up in products sold as DMT
  • If you cannot confirm the identity, the safe move is not a smaller dose of an unknown, it is not dosing
More on DMT vapes and carts →
Step 2

The MAOI problem: ayahuasca and your medication

If you are drinking ayahuasca or taking pharmahuasca capsules, you are taking a monoamine oxidase inhibitor. That single fact drives almost every serious interaction on this page.

🧪

Why oral DMT needs an MAOI

Monoamine oxidase in the gut wall and liver destroys DMT before meaningful amounts reach the brain, so swallowing DMT on its own produces little or nothing. Ayahuasca solves this by pairing a DMT-containing plant with Banisteriopsis caapi, whose harmala alkaloids (harmine, harmaline, tetrahydroharmine) inhibit MAO-A. Pharmahuasca does the same thing with isolated DMT plus harmine in a capsule. Self-experiments with pharmahuasca confirmed this mechanism directly, and it is the reason the oral route works at all.

Practical consequence: the MAOI stays active in your body for hours after the DMT is gone. The interaction window is not the length of the trip.

💊

SSRIs, SNRIs, and antidepressants

Critical

An MAOI on top of an SSRI or SNRI is a textbook serotonin syndrome combination and is contraindicated in ordinary psychiatric practice, entirely separately from any psychedelic context. Ayahuasca does not get an exemption from that pharmacology.

An important distinction people get wrong: recent reviews of taking antidepressants alongside classic psychedelics such as psilocybin found the combination generally tolerable without increased serotonin syndrome risk. That finding is about psilocybin and similar 5-HT2A agonists on their own. It does not transfer to ayahuasca, because ayahuasca adds an MAOI to the picture and the MAOI is what makes the interaction dangerous.

The other half of this is real too: stopping an antidepressant abruptly to attend a ceremony carries its own risk, including discontinuation effects and relapse of the condition you were treating. This is a conversation with a prescriber, not a decision to make off a website or from a facilitator's advice. If you cannot taper safely under supervision, the answer is to skip the ceremony.

How to recognise serotonin syndrome →
🚫

Do not combine with an MAOI

Critical
SSRIs / SNRIs Serotonin syndrome. Includes fluoxetine, sertraline, escitalopram, venlafaxine, duloxetine. Fluoxetine has a very long half-life and needs a much longer gap than the others
MDMA Serotonin syndrome, documented fatalities with MAOIs. No safe amount, no safe spacing on the same night
Tramadol Serotonin reuptake inhibition plus lowered seizure threshold. Severe and fast-developing with an MAOI
Other MAOIs Prescription phenelzine, tranylcypromine, or Syrian rue stacked with a caapi brew. Do not layer inhibitors
Stimulants Amphetamine, methamphetamine, cocaine, MDA. Hypertensive crisis risk from the sympathomimetic plus MAOI combination
Dextromethorphan (DXM) In many cough medicines. Serotonergic, and a recognised MAOI contraindication
Tyramine-rich food Aged cheese, cured and fermented meats, soy sauce, miso, sauerkraut, tap and unpasteurised beer, over-ripe or spoiled protein. Hypertensive crisis. Ceremony diets exist for a pharmacological reason
Decongestants Pseudoephedrine and phenylephrine are sympathomimetics with the same hypertensive risk as tyramine
Triptans, St John's wort, 5-HTP, lithium All add serotonergic load. Check every prescription and supplement, not just the obvious ones
Full interaction chart →
🩺

Serotonin syndrome warning signs

Onset is usually within hours of the triggering dose. The combination of these signs matters more than any one of them:

  • Agitation, restlessness, confusion, rapid speech
  • Muscle twitching, tremor, rigidity, and clonus (rhythmic involuntary jerking, most obvious at the ankles)
  • Heavy sweating, shivering, dilated pupils, diarrhoea
  • Fast heart rate, high blood pressure, rising temperature
High fever with muscle rigidity is a medical emergency. Call emergency services and tell them exactly what was taken, including the plant brew and any prescription medication. Cool the person while you wait. Do not give more serotonergic drugs of any kind.
🤢

What ayahuasca normally does

In the Global Ayahuasca Survey of more than 10,000 participants, about 70 percent reported an acute physical adverse effect, overwhelmingly vomiting, and 2.3 percent needed medical attention afterwards. Around 56 percent reported some adverse mental health effect in the following weeks, although most of those people framed it as part of a difficult but useful process, and about 12 percent sought professional support for it.

  • Vomiting and diarrhoea are expected, not a sign something went wrong. Plan for fluids afterwards
  • Physical adverse effects were more likely in people with an existing physical health condition and in people drinking outside a supervised setting
  • Adverse mental health effects were more likely in people with an anxiety disorder
  • Brew strength is not standardised. The same volume from a different batch is not the same dose
Step 3

Testing: what Ehrlich can and cannot tell you

Reagent testing for DMT is a rule-out tool, not an identification. Understanding exactly what the purple means keeps you from over-trusting it.

🧪

Ehrlich reagent

Ehrlich's is p-dimethylaminobenzaldehyde in acid. It condenses with the electron-rich indole ring and produces a purple product. That is the entire mechanism, and it explains both the value and the limit.

SampleEhrlich result
N,N-DMT Purple
5-MeO-DMT Purple (also an indole)
LSD Purple
Psilocybin material Purple, often muddy
NBOMe, DOx, most phenethylamines No reaction
Purple does not mean N,N-DMT. It means an indole is present. 5-MeO-DMT gives the same purple, so Ehrlich cannot do the one separation that matters most for this drug. A non-reaction is the informative result: whatever you have, it is not a tryptamine.

Some links here are affiliate links and we may earn a commission at no extra cost to you. DanceSafe sells Ehrlich as its LSD kit, which is the same reagent you would use on a tryptamine.

Ehrlich (LSD) kit at DanceSafe → Full Ehrlich color chart →
🚨

Lab drug checking

Because no home reagent separates N,N-DMT from 5-MeO-DMT, a lab service running GC-MS or FTIR is the only way to actually identify what you have. If the identity matters to you, and with these two compounds it should, this is the step that answers the question.

Scales and fentanyl strips

Weigh crystal rather than eyeballing it. The gap between a light smoked dose and a full breakthrough is small enough in milligrams that a visual estimate is not a dose.

Fentanyl contamination is not a documented feature of the DMT supply the way it is for opioids and some stimulant powders, so strips are not the priority here. If your source also handles powders where contamination does happen, or you have any doubt about what a shared bag has touched, strips are inexpensive insurance.

Step 4

Dose and timeline

Route changes this drug more than dose does. The same compound gives you a twelve-minute experience or a five-hour one depending entirely on how it enters your body.

💨

Smoked or vaporised N,N-DMT

Onset is within seconds of the first full inhalation. In controlled intravenous dosing, blood levels and subjective effects peaked within about two minutes and were negligible by thirty minutes. Smoked material follows a similar shape.

0–30 sec Onset. Already happening before you can put the pipe down
~1–3 min Peak. Most intense point of the experience
5–20 min Descent and return to baseline for most people
20–60 min Afterglow, mild disorientation, not a good window for driving

Because the window is so short, the temptation to immediately redose is strong. Repeated closely spaced dosing is not a neutral act: it stacks cardiovascular effects while, unusually, the subjective effects do not blunt. See the tolerance section below.

🍵

Oral (ayahuasca, pharmahuasca)

Plain oral DMT is inactive. With an MAOI, onset is typically 30 to 60 minutes, the peak sits around one to two hours, and the whole thing runs roughly four to six hours, with the MAOI itself active for longer.

  • Brew concentration varies between batches, preparers, and traditions. There is no reliable way to know the DMT content of a cup by looking at it
  • Do not treat a second cup as a proportional step up. Onset is slow enough that people misjudge it and drink again too early
  • The dietary and medication restrictions before a ceremony exist because of the MAOI, not for ritual reasons alone
  • Vomiting is common and expected
🌿

Changa and vape carts

Changa is DMT infused into a herbal blend, often with a caapi or Syrian rue component, which means it can carry a small MAOI dose alongside the DMT. If you take an SSRI or SNRI, or you are dosing anything else serotonergic, changa is not a lower-commitment option, it is a smaller version of the same interaction.

Vape carts split what would be one hit into many small ones. That changes the shape of the experience, makes accidental stacking easy, and removes your ability to inspect or weigh the material. Treat a cart of unknown provenance as an unidentified tryptamine at an unknown concentration.

Step 5

Physical safety and the sitter

Most of what goes physically wrong with smoked DMT is mundane: burns and falls. The onset is faster than your reaction time, so every precaution has to be in place before the first inhalation.

🛋

Before you light anything

  • Sit or lie down first. Not "I will sit down after". You will not have time. Standing is how people fall into furniture and hard floors
  • Have a sober sitter. Their first job is taking the pipe or vape out of your hand the moment you stop inhaling
  • Clear the area. No candles, no open flame, no glass tables, no stairs, no water, no balcony, no fireplace edges
  • Use a stable surface. A floor with cushions beats a couch you can roll off. Beds are fine if there is nothing hard beside them
  • Set the pipe down on something heatproof. Hot glass on a carpet or a duvet is a fire, and hot glass against skin is a burn you will not feel happening
  • Agree the plan out loud beforehand. The sitter should know what was taken, roughly how much, and that they are not to intervene physically unless there is a safety issue
🧍

What a sitter actually does

  • Takes the pipe, puts it somewhere safe, stays within reach
  • Does not talk, touch, or intervene unless the person is at physical risk
  • Keeps them from standing or wandering for the first several minutes
  • Watches for choking if the person vomits, and turns them onto their side if they are unresponsive and lying flat
  • Stays sober. A sitter who has also dosed is a second person needing supervision
  • Knows when to call for help and is willing to do it. In an emergency say what was taken, honestly

With 5-MeO-DMT the sitter role is more physical, not less. Rigidity, thrashing, and unresponsiveness are commonly described, and someone needs to be there to keep the person from injuring themselves.

🧠

Difficult experiences

A frightening DMT experience is short by construction. That is genuinely useful information to hold onto, and worth saying to someone out loud if you are sitting for them.

  • Slow breathing helps more than anything else. Long exhales
  • Do not fight it. Resistance during the peak tends to make it harder, and the peak passes on its own in minutes regardless
  • Fireside Project (62-FIRESIDE) takes calls and texts during and after psychedelic experiences
  • Oral doses do not have this escape hatch. An ayahuasca session you want out of still has hours left to run, which is why setting and support matter far more there
  • If distress persists for days afterwards, that is worth taking to a clinician rather than waiting out

Who should not take DMT

These are the risk factors with the clearest basis. None of them are absolute predictions, and all of them are reasons to take the decision seriously rather than casually.

🧬

Psychosis history

A personal or first-degree family history of schizophrenia, schizoaffective disorder, or bipolar disorder with psychotic features is a standard exclusion in every psychedelic clinical trial protocol, for good reason. Serotonergic psychedelics can precipitate or worsen psychotic episodes in vulnerable people. Family history counts even if you have never had symptoms yourself.

💓

Cardiovascular conditions

Controlled dosing produced dose-dependent rises in blood pressure and heart rate. Uncontrolled hypertension, arrhythmia, structural heart disease, or a history of cardiac events all make that acute surge a meaningful risk. With an MAOI on board, the hypertensive crisis risk from any sympathomimetic or tyramine exposure is added on top.

🤰

Pregnancy

There is no safety data on DMT or ayahuasca in pregnancy, and the alkaloids cross biological barriers. Harmala alkaloids in particular have uterine effects described in the older literature. Absence of data here is not reassurance, it means the risk is unquantified. The same applies while breastfeeding.

💊

Serotonergic medication

Any SSRI, SNRI, MAOI, tricyclic, tramadol, triptan, lithium, or St John's wort. For smoked N,N-DMT the concern is additive serotonergic load. For anything involving an MAOI it moves from concern to contraindication.

🧾

Liver conditions

Ayahuasca alkaloids are hepatically metabolised and interact with CYP enzymes. Existing liver disease or a medication regimen that already loads the liver is a reason to get clinical advice rather than proceed on a facilitator's assurance.

Tolerance and dependence

DMT behaves differently here from the rest of the psychedelic class, and that difference has a practical consequence.

Tolerance does not build the usual way

LSD and psilocybin build strong, fast tolerance: dose again the next day and the effect is markedly reduced. DMT does not follow that pattern. In a controlled study where volunteers received four hallucinogenic intravenous doses spaced thirty minutes apart, tolerance to the psychedelic subjective effects did not develop, by either clinical interview or rating scale. Hormonal responses and heart rate response did decline with repetition, while blood pressure response did not.

The harm reduction reading of that result: repeat dosing keeps working psychologically, so nothing in the experience tells you to stop, while cardiovascular effects are still landing each time. Decide your number of doses before you start rather than in the moment.

What DMT does not do

  • No documented physical withdrawal syndrome. Unlike alcohol, benzodiazepines, or opioids, stopping does not produce a recognised withdrawal state
  • Compulsive use is uncommon. In a survey of 515 people who had used 5-MeO-DMT, most had used fewer than four times in their life and under ten percent reported any craving or desire for the drug. Reported legal, medical, and psychiatric problems related to use were each around one percent
  • That is not the same as harmless. Low dependence liability says nothing about acute risk, the MAOI interactions, psychological difficulty, or what happens when the identity of the substance is wrong
  • Survey data is self-reported and drawn from people willing to answer a psychedelics questionnaire, which is not a representative sample. Read it as a signal about dependence patterns, not as a safety guarantee

Research and further reading

Human research on DMT is unusually good for a Schedule I tryptamine, largely because of one controlled programme in the 1990s. Research on 5-MeO-DMT is much thinner, and most of what is known about it comes from survey and metabolic work rather than clinical trials.

Human clinical

Strassman & Qualls (1994), dose-response in humans

Double-blind, placebo-controlled intravenous dosing in 11 experienced hallucinogen users. Peak blood levels and subjective effects within two minutes, negligible at thirty. Blood pressure, heart rate, pupil diameter, and body temperature all rose dose-dependently. This anchors both the timeline and the cardiovascular warning on this page.

Strassman RJ, Qualls CR (1994). Dose-response study of N,N-dimethyltryptamine in humans. I. Neuroendocrine, autonomic, and cardiovascular effects. Arch Gen Psychiatry. PMID 8297216 →
Tolerance

Strassman et al. (1996), differential tolerance

Thirteen volunteers received four hallucinogenic intravenous doses at thirty-minute intervals. Tolerance to the subjective psychedelic effects did not occur, while ACTH, prolactin, cortisol, and heart rate responses declined and blood pressure response did not. This is the source for the tolerance section above.

Strassman RJ, Qualls CR, Berg LM (1996). Differential tolerance to biological and subjective effects of four closely spaced doses of N,N-dimethyltryptamine in humans. Biol Psychiatry. PMID 8731519 →
Oral route

Ott (1999), pharmahuasca

Summary of roughly seventy self-experiments with capsules of crystalline DMT plus harmine. Confirms the Holmstedt-Lindgren hypothesis that oral DMT becomes active because the beta-carboline inhibits monoamine oxidase. This is the direct evidence behind the claim that oral DMT is inactive without an MAOI.

Ott J (1999). Pharmahuasca: human pharmacology of oral DMT plus harmine. J Psychoactive Drugs. PMID 10438001 →
Fatality

Sklerov et al. (2005), fatal 5-MeO-DMT intoxication

A 25-year-old man died after drinking herbal extracts containing beta-carbolines and tryptamines. Heart blood contained 5-MeO-DMT at 1.88 mg/L alongside harmine, harmaline, and tetrahydroharmine, with only trace N,N-DMT. No anatomic cause of death was found at autopsy and the medical examiner ruled hallucinogenic amine intoxication. This is the documented case behind the 5-MeO-DMT plus MAOI warning.

Sklerov J et al. (2005). A fatal intoxication following the ingestion of 5-methoxy-N,N-dimethyltryptamine in an ayahuasca preparation. J Anal Toxicol. PMID 16356341 →
Metabolism

Shen et al. (2010), 5-MeO-DMT metabolism and interactions

Review of how 5-MeO-DMT is handled by the body. It is inactivated mainly by MAO-A and converted by CYP2D6 into the active metabolite bufotenine. Adding harmaline blocks the deamination route, prolonging and increasing exposure to both, which the authors describe as a route to hyperserotonergic effects and serotonin toxicity. CYP2D6 genetic variation adds further unpredictability.

Shen HW, Jiang XL, Winter JC, Yu AM (2010). Psychedelic 5-methoxy-N,N-dimethyltryptamine: metabolism, pharmacokinetics, drug interactions, and pharmacological actions. Curr Drug Metab. PMID 20942780 →
5-MeO overview

Ermakova et al. (2022), narrative synthesis

Literature review covering the pharmacology, chemistry, and metabolism of 5-MeO-DMT. Identifies it as a serotonergic agonist with highest affinity for 5-HT1A, notes its short duration and relative lack of visual effects compared with other psychedelics, and states plainly that clinical studies in humans are lacking.

Ermakova AO, Dunbar F, Rucker J, Johnson MW (2022). A narrative synthesis of research with 5-MeO-DMT. J Psychopharmacol. PMID 34666554 →
Adverse effects

Bouso et al. (2022), Global Ayahuasca Survey

Survey of 10,836 ayahuasca drinkers across more than 50 countries. Around 70 percent reported acute physical adverse effects, mainly vomiting, with 2.3 percent requiring medical attention. Adverse mental health effects in following weeks were reported by around 56 percent, most of whom framed them as part of a growth process, with about 12 percent seeking professional support.

Bouso JC et al. (2022). Adverse effects of ayahuasca: Results from the Global Ayahuasca Survey. PLOS Glob Public Health. PMID 36962494 →
Antidepressants

Tap et al. (2025), antidepressants with classic psychedelics

Scoping review of 18 studies on taking conventional antidepressants alongside classic psychedelics. Found the combination generally safe and tolerable without increased serotonin syndrome risk, particularly for psilocybin, and argued that forced discontinuation carries its own harms. Read this as being about psilocybin-type psychedelics, not about ayahuasca, where the MAOI changes the picture entirely.

Tap SC et al. (2025). Concomitant use of antidepressants and classic psychedelics: A scoping review. J Psychopharmacol. PMID 40937732 →
MAOI safety

Flockhart (2012), MAOI dietary and drug interactions

Clinical pharmacology review of what MAOIs interact with. Covers hypertensive crisis from tyramine-containing foods and serotonin syndrome from serotonergic and sympathomimetic agents. Written for prescribers, but it is the same enzyme inhibition that ayahuasca produces, and it is the basis for the food and medication list above.

Flockhart DA (2012). Dietary restrictions and drug interactions with monoamine oxidase inhibitors: an update. J Clin Psychiatry. PMID 22951238 →
Patterns of use

Davis et al. (2018), 5-MeO-DMT epidemiology

Web survey of 515 people who had used 5-MeO-DMT. Most had used it fewer than four times in their lifetime and less than once a year. Under 10 percent reported craving or desire for the drug, and around 1 percent each reported legal, medical, or psychiatric problems related to use. The authors conclude a low potential for addiction. Self-selected sample, so treat it as a signal rather than a population estimate.

Davis AK et al. (2018). The epidemiology of 5-methoxy-N,N-dimethyltryptamine (5-MeO-DMT) use. J Psychopharmacol. PMID 29708042 →
Drug info

TripSit DMT page

Community-maintained dose ranges, duration, and a combination checker. Useful for checking a specific pairing before you commit to it.

TripSit: DMT →
Analytics

Drug checking services

Because Ehrlich cannot separate N,N-DMT from 5-MeO-DMT, laboratory analysis is the only way to identify a sample. Energy Control operates an international mail-in service and publishes aggregate results.

Energy Control (international analytics) →

DMT testing kit

Affiliate disclosure: links may earn a commission at no extra cost to you. Products selected for harm reduction value only.

Essential

Ehrlich reagent (sold as the LSD kit)

The one reagent that reacts with tryptamines. It confirms an indole is present and rules out non-indole substitutes. It will not tell you whether you have N,N-DMT or 5-MeO-DMT, so read the testing section above before relying on it.

Optional

Complete reagent set

All nine DanceSafe reagents together. Worth it if you test more than one class of substance, since Ehrlich alone covers only indoles.

Situational

Fentanyl test strips

Not a routine step for DMT crystal specifically, but useful if the same source or environment also handles powders where contamination is a documented problem.